Digital Health & Market Access
Connecting technological innovation with commercial viability. Market access strategies, health economics, and validation of digital tools for the modern patient.
SERVICES (Feature List)
Market Access Strategies:
Development of value propositions, pricing, and reimbursement dossiers, and navigation through public and private health systems.
Health Economics (HEOR):
Cost-effectiveness studies and budget impact analysis to demonstrate the economic value of your product to payers.
Digital Health:
Validación clínica y regulatoria de apps de salud, software as a medical device (SaMD) y plataformas de telemedicina.
Real World Evidence (RWE):
Design of observational studies to generate real-world evidence that complements traditional clinical trials.
Digital Transformation:
Advisory services to integrate digital tools into the medical and commercial departments of the pharmaceutical industry.
DIFFERENTIATION (The Value)
Innovation with Compliance. The biggest challenge in digital health is not technology, but regulation and adoption. At Clinical Biotec, we ensure your digital solution is not only functional but also compliant with data protection regulations (GDPR) and medical device requirements, facilitating real adoption within the
Do you have a technology ready for the market, or do you need to justify your drug's pricing?
Clinical Biotec S.L. – Spanish Tax ID (CIF): B56379233
Based in Madrid, Spain.
Registered in the Mercantile Registry of Madrid. We act as commercial representatives and authorized distributors for national and international companies in the technological, editorial, scientific, and academic sectors.
Email: santiago@clinicalbiotec.com
Copyright © 2023–2026 Clinical Biotec. All rights reserved.